Moreover, treatments for MM often cause even more immunosuppression: CD4 counts decrease after proteasome inhibitors (PIs) or monoclonal antibodies, whereas myelotoxicity, neutropenia, and decreased T-cell response, frequently follows therapy with immunomodulatory drugs (IMiDs). Here, CD4 is linked to neutropenia.